Skip to main content
Biorem Inc. logo

Biorem Inc. — Investor Relations & Filings

Ticker · BRM ISIN · CA09068G1046 LEI · 98450004A4A7BDOC3C84 TSXV Manufacturing
Filings indexed 154 across all filing types
Latest filing 2025-04-21 Regulatory Filings
Country CA Canada
Listing TSXV BRM

About Biorem Inc.

https://www.biorem.biz/

Biorem Inc. is a global clean technology engineering company specializing in the design, manufacture, and distribution of advanced air emissions control systems. The company focuses on the biological removal and abatement of odors, hydrogen sulfide (H2S), volatile organic compounds (VOCs), and hazardous air pollutants. Biorem's product portfolio includes modular and custom-engineered solutions such as BASYS and BiofiltAIR biofilters, MYTILUS biotrickling filters, multi-stage SYNERGY systems, biogas desulfurization units, and dry scrubber adsorption systems. These solutions are deployed across diverse sectors, including municipal wastewater treatment, petrochemical, industrial manufacturing, agriculture, and cannabis odor control. Leveraging over 30 years of experience, Biorem provides high-performance, guaranteed systems ranging from standard modular units to large-scale, field-erected installations.

Recent filings

Filing Released Lang Actions
52-109F1R - Certification of refiled annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109F2R certificate of refiled annual filings (Chief Executive Officer certification of the annual MD&A and financial statements). It is not the annual report itself, not management discussion (MDA), not an earnings release, nor a proxy or dividend announcement. It serves as a regulatory compliance filing under Canadian securities rules without fitting any specific category, so it defaults to the general Regulatory Filings category (RNS).
2025-04-21 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “MANAGEMENT’S DISCUSSION & ANALYSIS (‘MD&A’) For the Year Ended December 31, 2024,” containing management’s narrative explanation of the company’s operations, financial results, non-IFRS measures, quarterly summaries, outlook, and accounting policies. This aligns exactly with a Management Discussion and Analysis report. Consequently, the correct filing classification is MDA.
2025-04-21 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of Annual Filings” by the CEO of a Canadian venture issuer, certifying the accuracy of the annual AIF, financial statements, and MD&A. It does not itself contain financial statements or MD&A, nor is it announcing or attaching those reports; rather it is a regulatory certification form. This does not match an Annual Report (10-K), MD&A, or other substantive report category. Therefore it falls under the fallback category for miscellaneous regulatory filings.
2025-04-16 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 certification by the CFO confirming review and fair presentation of the annual filings for a Canadian venture issuer. It is a formal regulatory certification document rather than the actual annual report, earnings release, or MD&A content. This does not fit specific categories like 10-K, IR, MD&A, or Proxy, so it defaults to a general regulatory filing.
2025-04-16 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is clearly labeled as “Management’s Discussion & Analysis (MD&A)” for the year ended December 31, 2024. It provides management’s detailed commentary on financial performance, non-IFRS measures, segment trends, quarterly summaries, and forward-looking statements. It is not simply an earnings release or announcement, nor is it the full annual report (10-K) itself; rather it is the standalone MD&A section that accompanies the financial statements. This fits the definition of a Management Report (Code: MDA).
2025-04-16 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Canadian securities commission management certification form (Form 13-501F1) used to calculate and pay participation fees. It is neither an earnings release, annual or interim report, nor an investor presentation, legal notice, or voting declaration. There is no specific category for fee forms, so it falls under the general regulatory filings (RNS) catch‐all.
2025-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.